ITeos Therapeutics Net Tangible Assets

ITeos Therapeutics (ITOS) currently reports a net tangible assets of $490M as of June 2025. That compares with $660M in the prior-year period — down 25.6% year over year. Use the charts on this page to explore ITeos Therapeutics's net tangible assets history and peer comparisons.

ITeos Therapeutics's net tangible assets decreased from $660M to $490M — a 25.6% year-over-year decrease (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ITeos Therapeutics reported $490M in net tangible assets as of June 2025. That compares with $660M in the prior-year period — down 25.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $490M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ITeos Therapeutics, and consider following ITOS for alerts when major investors trade the stock.

ITeos Therapeutics is classified in the Healthcare sector. On net tangible assets, it currently shows $490M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ITOS with unrelated industries.